Drug Profile
Research programme: G protein-coupled receptors modulators - Pfizer/Ferring Pharmaceuticals
Alternative Names: GPCR modulators - Pfizer/FerringLatest Information Update: 16 Mar 2022
Price :
$50
*
At a glance
- Originator Arena Pharmaceuticals; Ferring Pharmaceuticals
- Class Small molecules
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Female infertility
Most Recent Events
- 11 Mar 2022 Arena Pharmaceuticals has been acquired and merged into Pfizer
- 31 Jul 2003 Discontinued - Preclinical for Female infertility in USA (unspecified route)
- 29 May 2002 Preclinical trials in Female infertility in USA (unspecified route)